What is De Nova Technology?
De Nova Technology operates as a specialized research and development entity dedicated to pioneering advancements in air filtration and respiratory safety. The company's product portfolio is characterized by high-utility innovations, such as the ViruShield Ghost, a transparent respiratory shield, and PawPadsRx, which provides protective adhesive solutions for pets. By integrating sophisticated engineering with consumer-centric design, the firm addresses critical needs for comfort and safety in extreme environments. Their technological stack includes advanced mask systems that feature active cooling mechanisms and integrated Bluetooth communication, positioning the company as a unique player at the intersection of personal protective equipment and wearable technology.
How much funding has De Nova Technology raised?
De Nova Technology has raised a total of $195K across 1 funding round:
Debt
$195K
Debt (2021): $195K with participation from PPP
Key Investors in De Nova Technology
PPP
Public-Private Partnership
What's next for De Nova Technology?
Following this major strategic investment, De Nova Technology is expected to prioritize the commercialization of its next-generation respiratory devices. The late-stage funding context suggests a shift from foundational R&D toward aggressive market penetration and supply chain optimization. Future strategic initiatives will likely focus on expanding the distribution of their flagship products into broader consumer markets and potentially exploring new applications for their proprietary filtration technology. As the company matures, the focus will remain on maintaining its competitive edge through continuous innovation while scaling its manufacturing capacity to meet the rising demand for high-performance, comfortable, and technologically integrated safety solutions.
See full De Nova Technology company page
